Form 8-K - Current report:
SEC Accession No. 0001144204-17-018018
Filing Date
2017-03-31
Accepted
2017-03-31 12:46:28
Documents
3
Period of Report
2017-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v463206_8k.htm 8-K 17649
2 EXHIBIT 99.1 v463206_ex99-1.htm EX-99.1 22269
3 GRAPHIC image_001.jpg GRAPHIC 9766
  Complete submission text file 0001144204-17-018018.txt   54949
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 17729197
SIC: 2834 Pharmaceutical Preparations